TP53 and lung carcinoma: For instance, miR-660 was reported as downregulated in in lung cancer patients and its transient and stable overexpression using RNA mimics reduced migration, invasion, and proliferation properties and increased apoptosis in p53 wild-type lung cancer cells (64).